First in class neuroprotective small molecule for ischemic stroke

Patent number:

EP21382409

No items found.

Small molecule that stabilizes the retromer complex, showing strong neuroprotective effects in highly excitotoxic conditions and maintaining key neuronal survival proteins like KIDINS220 in validated in‑vitro models.

Countries:
Spain
Regions:
Community of Madrid
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

R55‑treated mice remained on the beam for a longer time during the walking test, exhibiting fewer falls and slips compared to vehicle‑treated animals. T2‑weighted MRI analysis further showed that R55 treatment significantly reduced infarct volume. Together, these results demonstrate the strong neuroprotective effect of R55 and support its clinical potential — along with related compounds — to prevent excitotoxic neuronal death and brain damage caused by ischemic stroke.

Comments

Other related patents

Health

WEARABLE DEVICE, SYSTEM AND METHOD FOR MONITORING HOMEOSTATIC STATE

Countries
Spain
Know more
Health

PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTS

Countries
Spain
Know more
Health

SULFATED C19 STEROID HORMONES TO PROTECT AGAINST AGING-ASSOCIATED PROTEOTOXICITY

Countries
Spain
Know more
Get back to patents directory